Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Biotage Dividend Announcement
• Biotage announced a annually dividend of kr1.60 per ordinary share which will be made payable on 2024-05-03. Ex dividend date: 2024-04-26
• Biotage annual dividend for 2024 was kr1.60
• Biotage annual dividend for 2023 was kr1.60
• Biotage's trailing twelve-month (TTM) dividend yield is 0.98%
• Biotage's payout ratio for the trailing twelve months (TTM) is 49.81%
Biotage Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-04-26 | kr1.60 | annually | 2024-05-03 |
2023-04-28 | kr1.60 | annually | 2023-05-05 |
2022-04-29 | kr1.55 | annually | 2022-05-05 |
2021-04-29 | kr1.50 | annually | 2021-05-05 |
2019-04-25 | kr1.50 | annually | 2019-05-02 |
2018-04-27 | kr1.40 | annually | 2018-05-04 |
2017-04-28 | kr1.25 | annually | 2017-05-05 |
2016-04-29 | kr0.25 | annually | |
2015-04-29 | kr0.75 | annually | |
2014-04-29 | kr0.60 | annually | |
2013-04-26 | kr0.50 | annually | |
2012-04-27 | kr0.40 | annually |
Biotage Dividend per year
Biotage Dividend growth
Biotage Dividend Yield
Biotage current trailing twelve-month (TTM) dividend yield is 0.98%. Interested in purchasing Biotage stock? Use our calculator to estimate your expected dividend yield:
Biotage Financial Ratios
Biotage Dividend FAQ
Other factors to consider when evaluating Biotage as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Biotage stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Biotage's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Biotage publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Biotage distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Biotage are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Biotage sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Biotage distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Biotage declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Biotage's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Biotage's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.